Inflation is running hot, the RBI is leaning tighter, and the rupee has weakened, which means exporters are suddenly in a very different spotlight. That mix can punish some balance sheets while giving others unexpected pricing power and currency support. This article walks through three export driven Indian stocks that sit squarely in the path of these crosswinds and explains how each may factor into portfolio decisions in the current environment.
The three exporters covered below are just a sample set, and the full screen on Simply Wall St surfaced 4 more listed Indian companies with equally compelling export stories that are not discussed here but may warrant a closer look. To go straight to the source and identify, compare, and analyze potential high conviction ideas, head into the Indian Export-Oriented Stocks screener .
Aequs (NSEI:AEQUS)
Overview:Aequs is a contract manufacturer that runs an integrated aerospace and consumer products platform, supplying global customers across aviation, cookware, electronics and toys.
Operations:Aequs currently generates about ₹11,382 million from its Aerospace segment and ₹2,322 million from Consumer, highlighting aerospace as its primary revenue engine.
Market Cap:₹183.4 billion
For an export-focused investor, Aequs connects directly to the theme, since its aerospace value chain and consumer products both plug into overseas demand that can benefit when the rupee stays weaker for longer.
"Aequs is already an established, fully integrated aerospace supplier with USD 814 million of contracts running out to 2031, so a sustained shift of more content to Indian vendors could support higher aerospace revenues and help absorb fixed costs."
What happens to margins and cash generation if one unseen pressure on that long contract pipeline moves even slightly in Aequs' favor?
If that contract leverage is starting to quietly tilt Aequs' way, the full narrative for Aequs explains how factors such as currency, capacity and customer mix could be accelerating the story.
Welspun (BSE:532144)
Overview:Welspun manufactures and sells steel pipes and related products for oil, gas, water and infrastructure projects across India and overseas.
Operations:Welspun generates roughly ₹166.5b from Steel Products and about ₹6.5b from Other activities, highlighting pipes as its economic backbone.
Market Cap:₹697.6b
Welspun is closely linked to the export theme because its large-diameter steel pipes serve global energy and water projects. As a result, currency movements and overseas orders both matter when assessing earnings resilience.
"Heavy reliance on large infrastructure and clean energy pipeline projects ties Welspun's future margin trajectory to sectoral tailwinds, but policy or technological shifts (such as rapid adoption of advanced non-steel materials or delays in energy transition investments) could weaken medium-term earnings."
An important consideration is what may happen to Welspun's pricing power if a single key assumption about long-dated pipeline demand starts to move in the opposite direction.
If that assumption starts to break, the full narrative for Welspun shows where Welspun could still accelerate, slow, or fully decouple from those long project cycles.
Granules India (BSE:532482)
Overview:Granules India manufactures bulk drugs and finished medicines for global customers, giving Indian investors direct exposure to export-led pharmaceuticals.
Operations:Granules India currently earns about ₹56.3 billion from Pharmaceutical Products, reflecting a tightly focused, single segment revenue base.
Market Cap:₹201.7 billion
Granules India plugs straight into the export-oriented pharma theme, with a rupee cost base, foreign currency sales, and a growing presence in higher value drug ingredients and finished treatments that are linked to global healthcare demand.
"Expansion into the peptide CDMO and therapeutics market through acquisitions like Senn Chemicals has significantly increased capital employed and leverage. However, industry overcapacity, extended gestation periods for CDMO projects, and intense competition from well-established global peers could delay expected revenue contributions and profitability, weighing on ROCE and suppressing earnings for several years."
What happens to Granules India's earnings power if a single assumption about how quickly those new projects fill out proves too optimistic?
If that timing risk is on your mind, the full narrative for Granules India explains how Granules India could still convert those projects into either accelerating export earnings or a stalled reset.
Seeking Alternatives Before They Fly
Fresh ideas move first. By the time every screen lights up with momentum, the clean entries are often gone. Scan these under the radar lists while it matters and act now.
-
Spot resilient compounders early by running the 226 resilient stocks with low risk scores that prioritises balance sheet strength and steadier risk profiles before the crowd catches on.
-
Ride structural themes with a curated 16 nuclear energy infrastructure stocks focused on infrastructure players tied to long duration energy and grid projects, rather than short term hype.
-
Track the backbone of electrification using a targeted 16 top copper producer stocks that highlights producers positioned for wiring, renewables and long haul industrial demand.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
